Price change (24h):
0.39%
High (24h):
$0.03940859
Low (24h):
$0.03887896
Volume (24h):
$14.88
Market Cap:
$202.03K
All Time High:
99.39% $6.38
Dec 17, 2024
All Time Low:
25% $0.03
Jun 14, 2026
93.70 %(1Y)
$0.03906219
Price change (24h):
0.39%
High (24h):
$0.03940859
Low (24h):
$0.03887896
Volume (24h):
$14.88
Market Cap:
$202.03K
All Time High:
99.39% $6.38
Dec 17, 2024
All Time Low:
25% $0.03
Jun 14, 2026
PoSciDonDAO (SCI) is a cryptocurrency launched in 2024. It anchors the Decentralized Science (DeSci) sector, focusing on personalized medicine research funding.
The protocol targets structural inefficiencies in how life-altering disease therapies are financed. Traditional grant mechanisms suffer from bias, political influence, and sluggish capital distribution. The organization specifically channels capital into personalized medicine — an approach that identifies biomarkers predicting patient responses to treatments like cancer therapies. PoSciDonDAO replaces these legacy pipes with an on-chain coordination layer that pools resources for biomarker-driven studies.
The system operates on the Base network, a layer-2 rollup secured by Ethereum. This infrastructure slashes transaction fees, making frequent governance votes economically viable.
SCI is an ERC-20 utility token native to Base. It powers a set of audited governance contracts that enforce on-chain voting without intermediaries. The development roadmap also includes weCURA, a clinician aid for treatment matching, although SCI governance oversees its strategic direction. The token standard ensures compatibility with widely used Ethereum wallets and DeFi infrastructure.
The DAO materialized in December 2024, coinciding with growing skepticism about centralized grant authorities. Its launch document, a publicly accessible whitepaper, maps out how liquid democracy mechanisms can dissolve bottlenecks in cancer research funding. The project remains leaderless, a deliberate design choice to prevent capture.
PoSciDonDAO’s long-term aim is to build a predictive, transparent funding layer for precision medicine. The protocol channels collective intelligence toward the discovery of genetic markers that determine treatment success, potentially cutting years off the drug development cycle. It seeks to make clinical research funding more efficient and patient-centric, bypassing the slow, biased legacy grant machinery.
The SCI token enables voting on funding proposals, with each token equating to one vote in the DAO's decision-making processes. Treasury allocations for personalized medicine studies execute only after on-chain ratification. Only token holders can propose or amend the DAO’s funding allocation policies. This creates a closed-loop system where research capital is directed by those with the strongest financial stake in the ecosystem's success.
A medical researcher seeking capital for a biomarker study can submit a proposal to the DAO. SCI holders review, discuss, and cast votes; approved projects receive funding directly from the treasury. Large token custodians often delegate their voting power to domain experts, creating a meritocratic filtering layer.
PoSciDonDAO has a maximum supply of 18,910,000 tokens. Currently, 5,158,642.72 are in circulation. With a market capitalization of $310,228.00, PoSciDonDAO ranks #4,259 among all cryptocurrencies.
| Date | Open | Close | High | Low |
|---|---|---|---|---|
| 10/07/2026 | $0.04 | $0.04 | $0.04 | $0.04 |
| 06/07/2026 | $0.04 | $0.04 | $0.04 | $0.04 |
| 05/07/2026 | $0.04 | $0.04 | $0.04 | $0.04 |
| 03/07/2026 | $0.04 | $0.04 | $0.04 | $0.04 |
AI trades 24/7 automatically Catch every opportunity
Zero-emotion algorithm Disciplined strategy
Passive income Set & forget automation
20,000+
traders trusted Stoic AI
$200M+
in cumulative assets under management since inception
2015
year of company foundation
Disclaimer:
This website is operated by Cindicator Ltd. (“Cindicator”), a Gibraltar private company. You are solely responsible for compliance with all laws that may apply to you and your use of Cindicator products. Cryptocurrencies and blockchain technologies have been the subject of scrutiny by regulatory bodies worldwide. With respect to your use of Cindicator products, Cindicator makes no representations regarding the applicability or compliance of its products with any laws or regulations, including, without limitation, those related to trading, options, derivatives, or securities. You also assume all legal, economic, and other risks related to your use of Cindicator products, including legal uncertainty, market volatility, and information security risks, among others. Trading in cryptocurrencies and digital assets is highly speculative, and the value of investments can fluctuate dramatically. You may lose a substantial portion or even all of your invested capital, and such trading may not be suitable for everyone. If you are unsure about these risks or your ability to bear potential losses, you should consult with an independent financial advisor before using Cindicator products. Depending on your jurisdiction, access to or use of Cindicator products may be subject to certain legal restrictions or prohibitions. You agree that it is solely your responsibility to determine and comply with any laws and regulations applicable to your use of Cindicator products, and that Cindicator is not responsible for informing you of such requirements.
Cindicator reserves the right to restrict or refuse access to its products for citizens or residents of certain jurisdictions, including those subject to international sanctions or other legal restrictions. All materials provided on this website (including any graphical materials regarding trading strategy performance or P&L) are presented solely for marketing and informational purposes. They do not guarantee any future profits and should not be construed as financial, investment, legal, or other professional advice. Cindicator is not a registered broker-dealer, investment adviser, or regulated financial institution, and the information and services provided do not constitute personal investment advice or a recommendation or offer to buy or sell any securities, cryptocurrencies, or other financial instruments. The information provided herein is summary in nature, does not purport to be complete, and is provided “as is” without any warranty as to its accuracy or completeness. All content may be updated or changed at any time without notice. Past performance is not indicative of future results. To the maximum extent permitted by law, Cindicator (including its directors, officers, and affiliates) shall not be liable for any loss or damage (direct, indirect, special, consequential, or incidental) arising from your use of Cindicator products, this website, or any information contained herein. Please read our Terms of Use for further details. If you do not agree with these terms, please close this site.